Monday, June 18 10:00 am - 1:00 pm

SC1: Introduction to GPCR-Based Drug Discovery


Annette Gilchrist, PhD, Professor, Pharmacology, Midwestern University

Monday, June 18 2:30 - 5:30 pm

SC2: Enabling Macrocyclic Compounds for Drug Discovery


Eric Marsault, PhD, Professor, Medicinal Chemistry and Pharmacology, University of Sherbrooke

Mark Peterson, PhD, COO, Cyclenium Pharma, Inc.

SC3: Drug Metabolism and Its Impact on Decisions in Lead Discovery and Drug Development


Zhengyin Yan, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.

Donglu Zhang, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.

David Duignan, PhD, Principal Research Scientist, Drug Metabolism, Pharmacokinetics & Bioanalysis, AbbVie Bioresearch Center

Mingxiang Liao, PhD, Associate Director, Clinical Pharmacology and DMPK, Clovis Oncology

SC4: Practical Phenotypic Screening


Fabien Vincent, PhD, Associate Research Fellow, Hit Discovery and Lead Profiling Group, Pfizer

SC5: Impact of Convergence of Immunotherapy and Epigenetics in Oncology


Katherine Chiappinelli, PhD, Assistant Professor, Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University

Alejandro Villagra, PhD, Assistant Professor, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University

Wayne W. Hancock, MD, PhD, Professor of Pathology and Chief of Transplant Immunology, Children's Hospital of Philadelphia and University of Pennsylvania

SC6: Collecting, Storing, and Utilizing Precious Patient-Derived Tumors for Drug Discovery and Development


Mark A. Murakami, MD, Instructor in Medicine, Department of Medical Oncology, Dana-Farber Cancer Institute

Srivatsan Raghavan, MD, PhD, Instructor, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute

SC7: Introduction to Nanoparticles and Extracellular Vesicles for Drug Delivery


Hicham Fenniri, PhD, Professor, Chemical and Biomedical Engineering, Northeastern University

Additional Instructors to be Announced

SC8: Direct iN Conversion and iPSC Differentiation - Complementary Tools in Human Neural Disease Modeling


Jerome Mertens, PhD, Assistant Professor, Institute for Molecular Biology, University of Innsbruck, Staff Scientist, Laboratory of Genetics - Gage, Salk Institute

Monday, June 18 6:00 - 9:00 pm (Dinner Provided)

SC9: How to Best Utilize 3D Cells, Spheroids, PDX Models in Oncology


Madhu Lal-Nag, PhD, Group Leader, Trans-NIH RNAi Facility, National Center for Advancing Translational Sciences, National Institutes of Health

Geoffrey Bartholomeusz, PhD, Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Arvind Rao, PhD, Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center

SC10: Applications of Artificial Intelligence & Machine Learning in Drug Discovery & Development


Arvind Rao, PhD, Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center

Istvan Enyedy, PhD, Principal Scientist, Medicinal Chemistry, Biogen

Deepak Kumar Rajpal, Ph.D., Director, Computational Biology, GlaxoSmithKline

Ronald Alfa, MD, PhD, Vice President, Discovery & Product, Recursion Pharmaceuticals

SC11: Understanding and Dealing with Drug Disposition in CNS


Qin Wang, PhD, Principal Scientist, Translational Sciences, Biogen

Wednesday, June 20 6:30 - 9:30 pm (Dinner Provided)

SC12: Humanized Mouse Models for Preclinical Assessment of Cancer Immunotherapy


Barbara Joyce-Shaikh, Associate Principal Scientist, Merck Research Laboratories

Additional Instructors to be Announced

SC13: DNA-Encoded Library Technologies


Svetlana Belyanskaya, PhD, Scientific Leader, Encoded Library Technologies, R&D Platform Technology & Science, GSK Boston

SC14: Advanced Bioprinting Strategies for Generation of 3D Tissue Models


Margaret Prendergast, Director, Bioengineering, Allevi, Inc.

Ricky Solorzano, CEO, Allevi, Inc.

Yu Shrike Zhang, PhD, Research Faculty & Associate Bioengineer, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School & Harvard-MIT Division of Health Sciences and Technology

SC15: Evaluating and Characterizing in vitro Models of Drug Toxicity


Terry Van Vleet, PhD, DABT, Head of Molecular and Computational Toxicology, Department of Preclinical Safety, Abbvie

Will Proctor, PhD, Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech

SC16: Applications of CRISPR and Single-Cells: Best Practices from Set-Up to Data Analysis


Stephanie Mohr, PhD, Lecturer, Genetics & Director, Drosophila RNAi Screening Center at Harvard Medical School

Jennifer Smith, PhD, Deputy Director, ICCB-Longwood Screening Facility, Harvard Medical School

Sarah Boswell, PhD, Director of Sequencing Technologies, Laboratory of Systems Pharmacology and Director, Single-Cell Sequencing Core, Harvard Medical School

Roderick Beijersbergen, PhD, Group Leader, Netherlands Cancer Institute and Head, NKI Robotics and Screening Center

SC17: Use of Machine Learning to Help Reduce Gaps in Preclinical to Clinical Translation


S. Joshua Swamidass, MD, PhD, Assistant Professor, Department of Immunology and Pathology, Division of Laboratory and Genomic Medicine, Washington University

Additional Instructors to be Announced

*Separate registration required for Short Courses.

* 活动内容有可能不事先告知作更动及调整。